{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:42:08Z","timestamp":1785213728253,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270252"],"award-info":[{"award-number":["81270252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700305"],"award-info":[{"award-number":["81700305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800354"],"award-info":[{"award-number":["81800354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M651308"],"award-info":[{"award-number":["2019M651308"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Talent Project in Heilongjiang Province","award":["UNPYSCT--2017067"],"award-info":[{"award-number":["UNPYSCT--2017067"]}]},{"name":"Health Commission of Heilongjiang Province","award":["2014-376"],"award-info":[{"award-number":["2014-376"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118984","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T16:36:56Z","timestamp":1609173416000},"page":"118984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats"],"prefix":"10.1016","volume":"267","author":[{"given":"Chengchuang","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiankai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2020.118984_bb0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1159\/000480471","article-title":"Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.lfs.2020.118984_bb0015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/aps.2009.144","article-title":"Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo","volume":"30","author":"Zhang","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.lfs.2020.118984_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2008.04.054","article-title":"Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages","volume":"371","author":"Pae","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfq355","article-title":"Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy","volume":"26","author":"Tan","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.lfs.2020.118984_bb0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2012.11.014","article-title":"Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction","volume":"61","author":"Nakatani","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118984_bb0035","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.99.8.1084","article-title":"Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery","volume":"99","author":"Shiota","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.lfs.2020.118984_bb0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/13543776.2018.1531848","article-title":"Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010\u20132018)","volume":"28","author":"Ahmad","year":"2018","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.crd.0000195220.62533.c5","article-title":"Chymase: a new pharmacologic target in cardiovascular disease","volume":"14","author":"Bacani","year":"2006","journal-title":"Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000438605","article-title":"Anti-allergic drugs tranilast and ketotifen dose-dependently exert mast cell-stabilizing properties","volume":"38","author":"Baba","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.lfs.2020.118984_bb0055","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118984_bb0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1096\/fasebj.11.12.9337145","article-title":"Adriamycin cardiomyopathy: pathophysiology and prevention","volume":"11","author":"Singal","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2020.118984_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phymed.2018.01.009","article-title":"Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products","volume":"40","author":"Yu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2020.118984_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.toxlet.2019.09.024","article-title":"Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats","volume":"318","author":"Zhan","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2020.118984_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2017.06.003","article-title":"LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy","volume":"108","author":"Xia","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118984_bb0080","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1177\/0960327114532384","article-title":"Cardiotoxicity in rabbits after a low-level exposure to diazinon, propoxur, and chlorpyrifos","volume":"33","author":"Zafiropoulos","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.lfs.2020.118984_bb0085","doi-asserted-by":"crossref","first-page":"104276","DOI":"10.1016\/j.phrs.2019.104276","article-title":"MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1","volume":"146","author":"Zhao","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2020.118984_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118984_bb0095","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10554-017-1209-9","article-title":"Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction","volume":"33","author":"Zhou","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.lfs.2020.118984_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00280-019-04019-6","article-title":"Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats","volume":"85","author":"Sheibani","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"21","key":"10.1016\/j.lfs.2020.118984_bb0105","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1242\/jcs.200667","article-title":"Role of connexin 43 in different forms of intercellular communication - gap junctions, extracellular vesicles and tunnelling nanotubes","volume":"130","author":"Ribeiro-Rodrigues","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2020.118984_bb0110","doi-asserted-by":"crossref","unstructured":"Samak, M., et al., Cardiac hypertrophy: an introduction to molecular and cellular basis. Med Sci Monit Basic Res, 2016. 22: p. 75\u20139. DOI: 10.12659\/MSMBR.900437.","DOI":"10.12659\/MSMBR.900437"},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095585","article-title":"Protection against ovariectomy-induced bone loss by tranilast","volume":"9","author":"Phan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118984_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.lfs.2020.118984_bb0125","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO;2-3","article-title":"Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration","volume":"45","author":"Lee","year":"1980","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2020.118984_bb0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/jpet.105.099499","article-title":"The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo","volume":"317","author":"Greupink","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"25","key":"10.1016\/j.lfs.2020.118984_bb0135","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.etap.2015.06.019","article-title":"Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide-induced acute liver injury and hepatic encephalopathy","volume":"40","author":"Abdelaziz","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.lfs.2020.118984_bb0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00004872-200405000-00006","article-title":"Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug","volume":"22","author":"Pfab","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2020.118984_bb0155","first-page":"55(6)","article-title":"Morphological stages of mitochondrial vacuolar degeneration in phenylephrine-stressed cardiac myocytes and in animal models and human heart failure","author":"Chaanine","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.lfs.2020.118984_bb0160","article-title":"Salidroside attenuates doxorubicin-induced cardiac dysfunction partially through activation of QKI\/FoxO1 pathway","author":"Yan","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"3","key":"10.1016\/j.lfs.2020.118984_bb0165","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3892\/ijmm.2020.4669","article-title":"Doxorubicininduced oxidative and nitrosative stress: mitochondrial connexin 43 is at the crossroads","volume":"46","author":"Pecoraro","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118984_bb0170","doi-asserted-by":"crossref","first-page":"105619","DOI":"10.1016\/j.biocel.2019.105619","article-title":"ST2\/IL-33 signaling in cardiac fibrosis","volume":"116","author":"Vianello","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.lfs.2020.118984_bb0175","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.118984_bb0180","first-page":"9(7)","article-title":"Soluble St2 induces cardiac fibroblast activation and collagen synthesis via neuropilin-1","author":"Matilla","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2020.118984_bb0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fimmu.2019.00580","article-title":"Mast cells in cardiac fibrosis: new insights suggest opportunities for intervention","volume":"10","author":"Legere","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1165\/rcmb.2013-0399OC","article-title":"Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-beta1","volume":"52","author":"Cho","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118984_bb0195","doi-asserted-by":"crossref","unstructured":"Kim, K.K., D. Sheppard, and H.A. Chapman, TGF-beta1 signaling and tissue fibrosis. Cold Spring Harb. Perspect. Biol., 2018. 10(4). DOI: https:\/\/doi.org\/10.1101\/cshperspect.a022293.","DOI":"10.1101\/cshperspect.a022293"},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0200","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2020.118984_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-007-9676-2","article-title":"Chymase induces profibrotic response via transforming growth factor-beta 1\/Smad activation in rat cardiac fibroblasts","volume":"310","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.lfs.2020.118984_bb0215","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0220","first-page":"601","article-title":"Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation","volume":"48","author":"Lassegue","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118984_bb0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/hr.2012.2","article-title":"Short-term ACE inhibition confers long-term protection against target organ damage","volume":"35","author":"Hale","year":"2012","journal-title":"Hypertens. Res."},{"issue":"6","key":"10.1016\/j.lfs.2020.118984_bb0230","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.bjp.0707472","article-title":"Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats","volume":"152","author":"Liang","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118984_bb0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/CT:1:4:267","article-title":"Molecular mechanisms of cardiac hypertrophy induced by toxicants","volume":"1","author":"Chen","year":"2001","journal-title":"Cardiovasc. Toxicol."},{"issue":"3 Pt 2","key":"10.1016\/j.lfs.2020.118984_bb0240","first-page":"H1215","article-title":"Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats","volume":"271","author":"Kajstura","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2020.118984_bb0245","first-page":"118718","article-title":"Folic acid attenuates remodeling and dysfunction in the aging heart through the ER stress pathway","author":"Ye","year":"2020","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.lfs.2020.118984_bb0250","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jphp.12144","article-title":"Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118984_bb0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fcell.2020.00588","article-title":"Tranilast directly targets NLRP3 to protect melanocytes from keratinocyte-derived IL-1beta under oxidative stress","volume":"8","author":"Zhuang","year":"2020","journal-title":"Front Cell Dev Biol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520317446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520317446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T03:26:36Z","timestamp":1719890796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520317446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"alternative-id":["S0024320520317446"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118984","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118984"}}